Stachybotrys chartarum

From MicrobeWiki, the student-edited microbiology resource
This student page has not been curated.

1. Classification

a. Higher order taxa

Eukaryota (Kingdom), Fungi (Domain), Ascomycota (Phylum), Sordariomycetes (Class), Hypocreales (Order), Stachybotryaceae (Family), Stachybotrys (Genus [1].

b. Species

Stachybotrys chartarum

2. Description and significance

Stachybotrys chartarum, more commonly known as black mold, is a fungus prevalent in various environments, ranging from damp indoor spaces to food sources that both humans and livestock ingest [2]. Although its morphology and taxonomy were initially described in the 1830s by August Carl Joseph Corda, subsequent studies throughout the 20th century have raised questions about its size, ratio of conidia and phialides, and delineation from other species [3]. S. chartarum produces mycotoxins associated with detrimental health effects in humans and animals. It is the proposed pathogen for localized incidences of pulmonary hemorrhage in infants and other severe pulmonary conditions [4]. Current research efforts are still trying to discern the scope of its biological capabilities regarding indoor air quality and human health effects [3].

3. Genome structure

The complete genome of S.chartarum strain 51-11 spans approximately 40Mb [5]. With 9 sequence runs performed by Illumina Sequencing, there were approximately 736 million bases total, with about 2,600 bases per read5. The GC content for the S.chartarum genome is 53% [6]. Furthermore, based on the genes essential for satratoxin and atranone production (satratoxin cluster, SC1-3, sat or atranone cluster, AC1, atr), S. chartarum can be categorized into three groups: the S-type possessing all sat- but no atr-genes, the A-type lacking the sat- but harboring all atr-genes, and the H-type having only certain sat- and all atr-genes [6]. Genotype H is believed to represent the most ancient form of this fungus, with genotype S emerging from a loss of AC1 and the simultaneous acquisition of SC2 [6]. The development from genotype H to genotype A is believed to be accompanied by the loss of SC1 and SC3 [6].

4. Cell structure

S.chartarum, a gram-negative fungus, possesses a rigid cell wall primarily composed of chitin [7, 8]. When cultivated in media, it exhibits a dark color, giving rise to its common name. This fungus forms raised, circular colonies and consists of nonmotile bodies known as thalli, composed of apically elongating walled filaments (hyphae), which constitute the primary growth form of S. chartarum [9]. This structure can also branch out and become intertwined to form complex structures (e.g. rhizomorphs) [9]. Additionally, S. chartarum contains cellular cross walls called septa [8]. In S. chartarum, sporulation is triggered when food becomes depleted, as well as during its reproduction cycle [9].

Stachybotrys chartarum spores and conidiophore by Brendon Rawlings (not altered from original), licensed under BY-SA 3.0 Deed

5. Metabolic processes

S. chartarum exists in two chemotypes that produce different mycotoxins. Chemotype A produces atranones, while chemotype S produces macrocyclic trichothecenes [10]. The mutually exclusive production of either satratoxins or atranones defines the chemotypes A and S [6]. Macrocyclic trichothecenes include satratoxins, which are suspected to cause harm to humans and other animals [10]. Mycotoxin production and sporulation in S. chartarum are intertwined processes suspected to be regulated by G-protein signaling pathways, which also control developmental processes and stress responses [10]. The presence of neighboring colonies in strains of S. chartarum also stimulates mycotoxin production and sporulation [10]. S. chartarum is a chemoorganotroph which means that it obtains energy from the oxidation of organic compounds [11]. Nitrogen is a crucial element for the metabolism of S. chartarum; as nitrogen availability increases, it manufactures a higher mycotoxin production [10]. Common home building materials such as gypsum board, wood board, plywood, and cellulose insulation are all susceptible to S. chartarum decomposition under moist conditions [12]. S. chartarum produces an extracellular enzyme, cellulase, to digest and break down these home-building materials, which primarily consist of cellulose [13].

Stachybotrys chartarum growing on the walls of a house by Flikr user Thomas Anderson (not altered from original), licensed under BY-SA 2.0 Deed

6. Ecology

S. chartarum is found around the world, usually in areas high in cellulose [14]. It grows optimally in moist environments with a minimum water activity (aw) of at least 0.95 [15]. This poses a problem for flooded or damp homes, where S. chartarum can thrive. As moisture and aw decrease, so do the activity and growth of S. chartarum [15]. However, sporulation isn’t negatively affected when moisture decreases to an aw of 0.95. Thus, even when flooded homes are dried out, there is still a risk of spore contamination [15]. The optimal temperature for growth of this fungus is 30°C, although sporulation can still occur at temperatures reaching 15-20°C [15]. As the temperature deviates from 30°C, the total radial growth and rate of growth decreases [16]. Because of S. chartarum’s ability to decompose cellulose, buildings with cellulose insulation and wood supports are prime candidates for fungal growth [17]. S. chartarum generally does not compete well with other fungi and is rarely found outside [17]. However, this fungus has been found and isolated from soybean roots [18].

7. Pathology

S. chartarum affects the pulmonary health of humans. The mold releases spores and mycotoxins, toxic compounds to humans and some animals, including horses [19]. These toxins are found airborne in buildings with S. chartarum [20]. Pulmonary issues are attributed to the production of these toxins, where any growth of S. chartarum in buildings could cause illness in the residents [21]. Black mold causes nonspecific health-related problems, often called building-related illnesses or “sick building syndrome” [19]. Spore and toxin exposure activates an immune response that causes inflammation in the lungs [22, 23]. It can also cause arterial remodeling or airway obstruction [24, 25]. Symptoms may include those associated with interstitial lung disease (ILD), such as difficulty breathing or dry coughing [25]. The mold is also associated with skin and eye irritation [26].

S. chartarum poses a health hazard to animals as well. In 1945, an outbreak of "stachybotryotoxicosis" affected horses, other animals, and farm workers, causing excessive mucus discharge, mucous generation in the mouth, nose, and throat, lowered immunity, anemia, and death [20]. This resulted from ingesting farm feed infected by S. chartarum and its toxins [20]. Farm workers and animals showed disease symptoms when they inhaled farm dust and spores. Skin contact with infected vegetation also caused the skin to break and ooze [20].

There is speculation of an association between S. chartarum exposure and acute idiopathic pulmonary hemorrhage among infants [27]. This association was primarily due to an outbreak of cases in Cleveland, Ohio, from 1993 to 1998 in buildings that contained S. chartarum growth; however, the CDC could not determine a true association between disease outbreak and S. chartarum growth [27].

8. Cleaning Techniques

The presence of black mold or S. chartarum in damp homes and indoor environments requires treatment to prevent toxin exposure [28]. Cleaning techniques involving bleach and detergent have proven more effective in reducing toxins and spores compared to methods like steam cleaning and gamma irradiation [28]. The efficiency of antimicrobial cleaners has been tested, with Lysol All-Purpose Cleaner-Orange Breeze (full strength) ranking as the most effective, along with Borax and Orange Glo Multi-Purpose Degreaser being effective as well [29]. Antimicrobial paints can be applied to previously contaminated interior gypsum wallboards (drywall) to prevent regrowth after cleaning. A study found the most effective paints were Permawhite, M-1 Additive and Poterscept [30]. Chlorine dioxide gas has been utilized to treat indoor molds and eliminate their spores, but it was discovered that S. chartarum remained toxic even after exposure to this gas [31].

Stachybotrys chartarum growing on damp wallpaper in Brussels, Belgium, 2022” by Wikipedia user Antyo99 (not altered from original), licensed under BY-SA 4.0 Deed

9. Current Research

One area of current research delves into the health effects and detection methods associated with S. chartarum. In a study involving mice repeatedly exposed to two different strains, IBT 9460 (strain A) and IBT 7711 (strain B), of S. chartarum, researchers observed consistent inhalation-induced inflammation and arterial remodeling in the lungs [24]. Notably, strain A triggered a faster response to S. chartarum exposure than strain B [24]. Furthermore, individuals exposed to S. chartarum for at least three months reported heightened respiratory, dermatological, ocular, and fatigue symptoms [26]. These findings highlight the adverse health effects of repeated S. chartarum exposure, impacting the respiratory, central nervous, mucous, and immune systems.

Another significant area of research centers on the toxicity of S. chartarum and its implications for individuals residing in contaminated buildings. Occupants of such buildings have reported health issues linked to their environment [21]. Additionally, S. chartarum is known to produce two primary types of mycotoxins: Satratoxins and Atranones. While atranones exhibit lower toxicity compared to satratoxins, both mycotoxin types pose substantial health risks [8].

Advances in research have facilitated the identification of specific biomarkers associated with S. chartarum exposure. Clinical biomarkers, such as antibodies against S. chartarum and antigenic components like Stachyhemolysin and Stachyrase-A, have been successfully identified [32]. These biomarkers offer valuable diagnostic tools for accurately assessing S. chartarum exposure.

S. chartarum's adaptability is a growing concern. Researchers have discovered its presence not only in traditional indoor environments but also in soil and other cellulose-rich substances, indicating its ability to thrive in various settings [18]. This versatility raises additional concerns about the potential for exposure in different environments.

References

[1][Schoch CL, et al. NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020: baaa062. PubMed: 32761142 PMC: PMC7408187.] [2][Ulrich S, Schäfer C. Toxin Production by Stachybotrys chartarum Genotype S on Different Culture Media. Journal of fungi (Basel, Switzerland) 2020;6:159.] [3][Li DW, Yang CS. Taxonomic history and current status of Stachybotrys chartarum and related species. Indoor air 2005;15:5–10.] [4][Montana E, Etzel RA, Allan T, et al. Environmental Risk Factors Associated With Pediatric Idiopathic Pulmonary Hemorrhage and Hemosiderosis in a Cleveland Community. Pediatrics (Evanston) 1997;99:5.] [5][Betancourt DA, Dean TR, Kim J, et al. Genome Sequence of Stachybotrys chartarum Strain 51-11. Genome announcements 2015;3:e01114-15. https://doi.org/10.1128/genomeA.01114-15] [6][Ulrich S, Lang K, Niessen L, et al. The evolution of the satratoxin and atranone gene clusters of Stachybotrys chartarum. Journal of Fungi (Basel, Switzerland) 2022;8:340.] [7][Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clinical microbiology reviews 2003;16:144–172. https://doi.org/10.1128/CMR.16.1.144-172.] [8][Masten AS. Stachybotrys chartarum (or S. atra or S. alternans) [CAS No. 67892-26-6]: review of toxicological literature. National Institutes of Health 2004.] [9][Ekruth J, Gottschalk C, Ulrich S, et al. Differentiation of S. chartarum (Ehrenb.) S. Hughes Chemotypes A and S via FT-IR Spectroscopy. Mycopathologia 2020;185:993–1004.] [10][Tribelhorn K, Twarużek M, Soszczyńska E, et al. Production of Satratoxin G and H Is Tightly Linked to Sporulation in Stachybotrys chartarum. Toxins 2020;14:515.] [11][Amils R. Chemoorganotroph. Encyclopedia of Astrobiology. Springer 2011.] [12][Menetrez MY, Foarde KK, Webber TD, et al. Growth Response of Stachybotrys Chartarum to Moisture Variation on Common Building Materials. Indoor and Built Environment 2004;13:183-187.] [13][Thomas R. Fungal cellulases VII. Stachybotrys Atra: Production and Properties of the Cellulolytic Enzyme. Australian Journal of Biological Sciences 1956;9:159-183.] [14][Hossain MA, Ahmed MS, Ghannoum MA. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol. 2004;113:200-208.] [15][Frazer S, Magan N, Aldred D. The Influence of Water Activity and Temperature on Germination, Growth and Sporulation of Stachybotrys chartarum Strains. Mycopathologia 2011;172:17–23.] [16][Frazer S, Pestka J, Kim J, et al. Impact of environmental factors on growth and satratoxin G production by strains of Stachybotrys chartarum. World Mycotoxin Journal 2012;5: 37-43.] [17][Progovitz, RF (2003). Black Mold: Your Health and Your Home. The Forager Press.] [18][Li S, Hartman GL, Jarvis BB, Tak, H. A Stachybotrys chartarum isolate from soybean. Mycopathologia 2002;154:41–49.] [19][Köck J, Gottschalk C, Ulrich S, et al. Rapid and selective detection of macrocyclic trichothecene producing Stachybotrys chartarum strains by loop-mediated isothermal amplification (LAMP). Anal Bioanal Chem 2021;413:4801-13.] [20][Brasel TL,, Martin JM, Carriker CG, et al. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins in the indoor environment. Applied and Environmental Microbiology 2005;71:7376-88.] [21][Piontek M, Łuszczyńska K. Testing the toxicity of Stachybotrys chartarum in indoor environments—a case study. Energies 2021;14:1602.] [22][Lichtenstein JHR, Molina RM, Donaghey TC, et al. Pulmonary responses to Stachybotrys chartarum and its toxins: mouse strain affects clearance and macrophage cytotoxicity. Toxicological Sciences 2010;116:113-21.] [23][Leino M, Mäkelä M, Reijula K, et al. Intranasal exposure to a damp building mold, Stachybotrys chartarum, induces lung inflammation in mice by satratoxin-independent mechanisms. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2003;33:1603-10.] [24][Croston TL, Lemons AR, Barnes MA, et al. Inhalation of Stachybotrys chartarum fragments induces pulmonary arterial remodeling. Am J Respir Cell Mol Biol 2020;62: 563-76.] [25][Hodgson MJ, Morey P, Leung WY, et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J. Environ. Med. 1998;40:241-49.] [26][Johanning E, Biagini R, Hull D, et al. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. International Archives of Occupational and Environmental Health 1996;68:207-18.] [27][Centers for Disease Control and Prevention (CDC). Update: pulmonary hemorrhage/hemosiderosis among infants--Cleveland, Ohio, 1993-1996. Morbidity and Mortality Weekly Report 2000;49:180-84.] [28][Wilson SC, Brasel TL, Carriker CG, et al. An investigation into techniques for cleaning mold-contaminated home contents. Journal of Occupational and Environmental Hygiene 2004; 1:442-47.] [29][Menetrez MY, Foarde KK, Webber TD, et al. Testing antimicrobial cleaner efficacy on gypsum wallboard contaminated with Stachybotrys chartarum. Environmental Science and Pollution Research International 2007;14: 523-28.] [30][Menetrez MY, Foarde KK, Webber TD, et al. Testing antimicrobial paint efficacy on gypsum wallboard contaminated with Stachybotrys chartarum. Journal of Occupational and Environmental Hygiene 2008;5:63–66.] [31][Wilson SC, Wu C, Andriychuk LA, et al. Effect of chlorine dioxide gas on fungi and mycotoxins associated with sick building syndrome. Applied and Environmental Microbiology 2005;71:5399-5403.] [32][Vojdani A. Antibodies against Stachybotrys chartarum extract and its antigenic components, Stachyhemolysin and Stachyrase-A: a new clinical biomarker. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2005;11:139–45.]

11. Authorship Statement

Kate Pryor wrote the sections on General Description and Classification. Anvita Dandu wrote the sections on Genome Structure and Cell Structure. Brandon Kim wrote the sections on Metabolic Process and Ecology. Gabrielle Daley wrote the sections Pathology and Cleaning Techniques. Sabrina Wu wrote the section on Current Research.

Edited by Anvita Dandu, Brandon Kim, Gabrielle Daley, Kate Pryor, and Sabrina Wu, students of Jennifer Bhatnagar for BI 311 General Microbiology, 2023, Boston University.